FDA Clearance Tracker · P010047-S011
NEOMEND PROGEL PLEURAL AIR LEAK SEALANT
Last checked: Nov 20, 2026Latest source record: May 10, 2012 (this decision)Source: openFDAMethods & limitations
Decided
May 10, 2012
Approved
Time to decision
357 days
Received May 19, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010047-S011
- Device name
- NEOMEND PROGEL PLEURAL AIR LEAK SEALANT
- Applicant
- Neomend, Inc.
- Applicant location
- Irvine, CA
- Received
- May 19, 2011
- Decided
- May 10, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010047
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ADDITION OF NEOMEND, INCORPORATED, IRVINE, CALIFORNIA AS A SECOND SOURCE SUPPLIER FOR THE HUMAN SERUM ALBUMIN (HSA) PROTEIN CARTRIDGES FOR THE DEVICE.
Source documents
Other decisions for Neomend, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150016 · Decided Apr 11, 2016 · 350 days after receipt
Device type: Sealant, polymerizing (NBE) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.